FDANonrulemakingFDA-2011-D-0611

Who commented on this docket

Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009

3 organizations filed 5 public comments on Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009, at the Food and Drug Administration. The comment window closed 78d ago.

Organizations
3
Comments
5
RIN
Comment window
closed 78d ago

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.